DK131988A - IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE - Google Patents

IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE

Info

Publication number
DK131988A
DK131988A DK131988A DK131988A DK131988A DK 131988 A DK131988 A DK 131988A DK 131988 A DK131988 A DK 131988A DK 131988 A DK131988 A DK 131988A DK 131988 A DK131988 A DK 131988A
Authority
DK
Denmark
Prior art keywords
binding protein
dna structure
igf binding
vector containing
coding
Prior art date
Application number
DK131988A
Other languages
Danish (da)
Other versions
DK131988D0 (en
Inventor
Stenwert Leonard Sebastia Drop
Arend Brinkman
Original Assignee
Erasmus University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erasmus University filed Critical Erasmus University
Priority to DK131988A priority Critical patent/DK131988A/en
Publication of DK131988D0 publication Critical patent/DK131988D0/en
Priority to PCT/NL1989/000008 priority patent/WO1989008667A1/en
Priority to EP89903815A priority patent/EP0404812A1/en
Priority to JP1503492A priority patent/JPH03504494A/en
Priority to AU32965/89A priority patent/AU3296589A/en
Publication of DK131988A publication Critical patent/DK131988A/en
Priority to DK216690A priority patent/DK216690D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK131988A 1988-03-11 1988-03-11 IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE DK131988A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DK131988A DK131988A (en) 1988-03-11 1988-03-11 IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE
PCT/NL1989/000008 WO1989008667A1 (en) 1988-03-11 1989-03-10 Recombinant igf binding protein (ibp-1)
EP89903815A EP0404812A1 (en) 1988-03-11 1989-03-10 Recombinant igf binding protein (ibp-1)
JP1503492A JPH03504494A (en) 1988-03-11 1989-03-10 IGF-binding protein, a DNA construct encoding the IGF-binding protein, and a vector containing this DNA construct
AU32965/89A AU3296589A (en) 1988-03-11 1989-03-10 Recombinant igf binding protein (ibp-1)
DK216690A DK216690D0 (en) 1988-03-11 1990-09-10 RECOMBINANT IFG BINDING PROTEIN (IBP-1)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK131988A DK131988A (en) 1988-03-11 1988-03-11 IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE

Publications (2)

Publication Number Publication Date
DK131988D0 DK131988D0 (en) 1988-03-11
DK131988A true DK131988A (en) 1989-09-12

Family

ID=8103523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131988A DK131988A (en) 1988-03-11 1988-03-11 IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE

Country Status (5)

Country Link
EP (1) EP0404812A1 (en)
JP (1) JPH03504494A (en)
AU (1) AU3296589A (en)
DK (1) DK131988A (en)
WO (1) WO1989008667A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
JPH03504597A (en) * 1988-04-12 1991-10-09 シナージェン，インコーポレーテッド Methods for enhancing and inhibiting insulin-like growth factor activity
EP0424416B1 (en) * 1988-07-15 1995-07-19 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
ATE208816T1 (en) * 1990-08-28 2001-11-15 Chiron Corp NEW INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN IGFBP-5
US5212074A (en) * 1990-08-28 1993-05-18 Chiron Corporation Genetic material encoding new insulin-like growth factor binding protein igfbp-6
CA2090703A1 (en) * 1990-08-28 1992-03-01 Michael C. Kiefer Insulin-like growth factor binding protein (igfbp-4)
US6326154B1 (en) 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
EP0556344B1 (en) 1991-01-08 2003-08-13 Chiron Corporation New insulin-like growth factor binding protein
US5198340A (en) * 1991-01-17 1993-03-30 Genentech, Inc. Assay for free igf-i, igf-ii, and gh levels in body fluids
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
US6420172B1 (en) 1992-04-20 2002-07-16 Tib Company, Llc Method for inducing tumor immunity
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
ATE243712T1 (en) 1992-11-04 2003-07-15 Chiron Corp SHORTENED INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN WITH MITOGENIC ACTIVITY
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
JPH08508296A (en) * 1993-04-07 1996-09-03 アムジエン・ブルダー・インコーポレーテッド Method of using insulin-like growth factor binding protein
DE69423506T2 (en) * 1993-08-03 2000-09-21 Celtrix Pharma METHOD FOR TREATING REPRODUCTION DISEASES
DE69431534T2 (en) 1994-07-12 2003-06-26 Human Genome Sciences Inc Connective tissue growth factor-2
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
JPH10512235A (en) * 1994-07-20 1998-11-24 セルトリックス ファーマシューティカルズ，インコーポレイテッド IGF / IGFBP complex for promoting bone formation and regulating bone remodeling
US5994302A (en) * 1994-12-09 1999-11-30 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US5747280A (en) * 1995-06-05 1998-05-05 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
IL143834A0 (en) 1999-01-06 2002-04-21 Genentech Inc Insulin-like growth factor (igf) i mutant variants
ES2234560T3 (en) 1999-01-06 2005-07-01 Genentech, Inc. MUTANT VARIANTE OF THE INSULIN TYPE GROWTH FACTOR (IGF-I).
ATE389416T1 (en) 2000-05-16 2008-04-15 Genentech Inc TREATMENT OF CARTILARY DISEASES
CA2439735A1 (en) 2001-03-14 2002-09-19 Genentech, Inc. Igf antagonist peptides
PL2274978T3 (en) 2003-09-12 2015-11-30 Ipsen Biopharmaceuticals Inc Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency
US7192738B2 (en) 2003-10-03 2007-03-20 Genentech, Inc. IGF binding proteins
JP2020533344A (en) 2017-09-11 2020-11-19 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド Methods and Compositions for Treating Chronic Lung Disease
KR20230113287A (en) 2020-10-19 2023-07-28 오크 힐 바이오 리미티드 Compositions suitable for use in newborns
WO2023139115A1 (en) 2022-01-19 2023-07-27 Oak Hill Bio Limited Compositions and methods for reducing oxidation of igf‐1/igfbp
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338480A1 (en) * 1983-10-22 1985-05-02 Behringwerke Ag, 3550 Marburg NEW PROTEIN PP (DOWN ARROW) 2 (DOWN ARROW) (DOWN ARROW) 0 (DOWN ARROW), METHOD FOR ITS OBTAINMENT AND USE

Also Published As

Publication number Publication date
JPH03504494A (en) 1991-10-03
WO1989008667A1 (en) 1989-09-21
DK131988D0 (en) 1988-03-11
AU3296589A (en) 1989-10-05
EP0404812A1 (en) 1991-01-02

Similar Documents

Publication Publication Date Title
DK131988D0 (en) IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE
DK217889A (en) RECOMBINANT DNA EXPRESSION VECTORS AND DNA COMPOUNDS CODING FOR DESACETOXYCEPHALOSPORIN C SYNTHETASE
DE3669112D1 (en) TOURING SKI BINDING.
DK40086D0 (en) FORMAL HYDNEE BINDING MATERIAL, PROCEDURES FOR PREPARING IT AND USING THEREOF
DK100985A (en) DNA CODING FOR HUMAN TUMORNECROSE FACTOR, AND HUMANT TUMORNECROSE FACTOR POLYPEPTIDE AND PROCEDURES FOR PRODUCING IT
NO922155L (en) PEPTIDES AND ANTIBODIES INHIBITING INTEGRINIGANDAND BINDING
DK122687A (en) POLYPEPTID, DNA AND USE THEREOF
DK108189A (en) CHIMERARY ANTIBODIES AGAINST HUMANT CARCINOEMBRYONAL ANTIGEN AND METAL-CHELATES AND DNA SEQUENCES CODING FOR SUCH ANTIBODIES
DK317288A (en) HUMAN PROTEIN C HYBRID PROTEIN AND ITS PREPARATION AND DNA CODING IT
DK4387D0 (en) HUMAN-PRAEPO-INSULIN-LIKE FACTOR IN GENES AND SYNTHETIC DNA SEQUENCES CODING THIS
DK589085D0 (en) RECOMBINANT DNA EXPRESSION VECTOR WHICH IS FUNCTIONAL AND SELECTIVE IPLANTS
NO904024L (en) HEPARIN BINDING PROTEINS, DNA CODING THEM THEREOF, PROCEDURES FOR PREPARING IT AND THERAPEUTIC PREPARATIONS CONTAINING THEM.
DK300787A (en) CYTOMEGALIVIRUS DNA STRUCTURE, EXPRESSION VECTOR THEREOF, AND CODED PROTEIN INSTRUCTIONS AND THEIR USE
DK178386A (en) RECOMBINANT DNA EXPRESSION VECTOR AND DNA COMPOUNDS EXPRESSING ISOPENICILLIN N SYNTHETASE
GB8801877D0 (en) Nucleotide sequence encoding plant ribosome inactivating protein
DK102088D0 (en) RECOMBINANT DNA EXPRESSION VECTORS AND DNA PRODUCTS CODING DEACETOXYCEPHALOSPORIN C SYNTHETASE AND DEACETYLPHALOSPORINE C SYNTHETASE
DK606088D0 (en) RECOMBINANT DNA EXPRESSION VECTORS AND DNA COMPOUNDS CODING FOR ISOPENICILLIN N SYNTHETASE
DK224985A (en) PEPTIDES, AND AGENTS CONTAINING THE PEPTIDES
NO842682L (en) POLYPEPTIDE AND DNA SEQUENCE AND VECTOR
DK221389D0 (en) FIBRONECTIN BINDING PROTEIN AND PROCEDURE FOR PREPARING THEREOF
DK174933B1 (en) Modified hygromycin B resistance DNA sequence as well as plasmids, vectors and transformants containing this DNA sequence
DK151788A (en) HYBRID SERPINES AND DNA THAT CODES THEREOF
EP0267272A4 (en) Atrial natriuretic peptide receptor protein and its encoding dna.
DK164877C (en) HEPARIN BINDING PROTEIN (HBP), THERAPEUTIC PREPARATION CONTAINING HBP, PROCEDURE FOR PREPARING HBP PROTEIN, AND DNA SEQUENCE AND CDNA CODING FOR HBP
GB8716938D0 (en) Dna sequence coding

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment